BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30668804)

  • 21. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
    Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
    Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.
    Hiemcke-Jiwa LS; Leguit RJ; Snijders TJ; Jiwa NM; Kuiper JJW; de Weger RA; Minnema MC; Huibers MMH
    Crit Rev Oncol Hematol; 2018 Jul; 127():56-65. PubMed ID: 29891112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
    Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
    Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis.
    Wijaya JH; Patel UD; Quintero-Consuegra MD; Aguilera-Peña MP; Madriñán-Navia HJ; Putra AW; July J; Kataria S
    J Neurooncol; 2023 Dec; 165(3):431-438. PubMed ID: 38019327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
    Liu AP; Northcott PA; Robinson GW; Gajjar A
    Lab Invest; 2022 Feb; 102(2):134-142. PubMed ID: 34934181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
    Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
    J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.
    Rossi G; Mu Z; Rademaker AW; Austin LK; Strickland KS; Costa RLB; Nagy RJ; Zagonel V; Taxter TJ; Behdad A; Wehbe FH; Platanias LC; Gradishar WJ; Cristofanilli M
    Clin Cancer Res; 2018 Feb; 24(3):560-568. PubMed ID: 29180605
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
    Nordgård O; Tjensvoll K; Gilje B; Søreide K
    Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid biopsy: possibilities and limitations in uro-oncology.
    López-Guerrero JA; Pastor-Navarro B; Claramunt-Alonso R; García-Flores M; Rubio-Briones J
    Arch Esp Urol; 2022 Mar; 75(2):203-214. PubMed ID: 35332890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
    Mohanty A; Mohanty SK; Rout S; Pani C
    Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
    von Bubnoff N
    Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
    Escudero L; Martínez-Ricarte F; Seoane J
    Curr Opin Neurol; 2020 Dec; 33(6):736-741. PubMed ID: 33177377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How liquid biopsies can change clinical practice in oncology.
    Siravegna G; Mussolin B; Venesio T; Marsoni S; Seoane J; Dive C; Papadopoulos N; Kopetz S; Corcoran RB; Siu LL; Bardelli A
    Ann Oncol; 2019 Oct; 30(10):1580-1590. PubMed ID: 31373349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.
    Seoane J; De Mattos-Arruda L; Le Rhun E; Bardelli A; Weller M
    Ann Oncol; 2019 Feb; 30(2):211-218. PubMed ID: 30576421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.